Further detailed dissection of the mitotic functions of the FA pathway will be key to understanding the molecular pathogenesis of FA as well as the identification of therapeutically targetable vulnerabilities in FA-disrupted malignancies. The gene discussed is FANCA; the disease is Friedreich ataxia.